Founded Year
2005Stage
Convertible Note | AliveTotal Raised
$4.69MLast Raised
$250K | 6 yrs agoAbout RhinoCyte
RhinoCyte is a biotechnology company that has developed a method of isolating adult stem cells located in the olfactory regions of the mucosal lining of the human nasal passageway, which can be used in therapies for spinal cord injury, multiple sclerosis, ALS and Parkinson's Disease.
RhinoCyte Headquarter Location
1044 E. Chestnut Street
Louisville, Kentucky, 40204,
United States
502-410-4512
Expert Collections containing RhinoCyte
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
RhinoCyte is included in 2 Expert Collections, including Regenerative Medicine.
Regenerative Medicine
1,818 items
Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).
Biopharma Tech
5,238 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.